VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurchase
Filed with HKEX · Stock code 2595 · · 2 pages · English
Summary by 6ix AI
GenFleet Therapeutics (Shanghai), Inc. has issued a voluntary announcement regarding its share repurchase progress. As of a specified date, the company has repurchased a total of H Shares, representing a small percentage of its total issued shares. The company plans to continue its share repurchase plan based on market conditions, but there are no guarantees regarding timing or quantity. Shareholders and potential investors are advised to exercise caution when trading the company's H Shares due to market uncertainties.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genfleet Therapeutics (Shanghai), Inc. on 6ix
Earlier from Genfleet Therapeutics (Shanghai)
- Share repurchase
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
- VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of Oral Pan RAS Inhibitor GFH276 Recently Granted with Clinical Trial Approvals for First-line and Late-line Clinical Studies Addressing Major Tumor Indications in China or Abroad
Follow Genfleet Therapeutics (Shanghai) into a list and get an email when it puts out news.
Follow Genfleet Therapeutics (Shanghai)